GlassScriptPhysician profile
Nayneshkumar Patel
NPI 1154539807
$10,412.28
in general payments reported to CMS, 2019-2025
39 companies · $2,252 in 2025
The $2,252 reported for 2025 was more than what 88% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $851 · 2021: $1,387 · 2022: $1,533 · 2023: $2,005 · 2024: $1,407 · 2025: $2,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,310 · Education: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,309.94 |
| Education | $354.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,944.33 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,689.06 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $996.85 | 2019-2025 | Ofev, Jascayd |
| Mallinckrodt Hospital Products INC. | $894.18 | 2020-2025 | Acthar |
| Actelion Pharmaceuticals US, INC. | $547.96 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $527.96 | 2021-2025 | Dupixent |
| Genzyme Corporation | $475.96 | 2022-2025 | |
| Grifols USA, LLC | $458.32 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $366.60 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $227.90 | 2020-2025 | Glassia |
| United Therapeutics Corporation | $210.14 | 2022-2025 | Tyvaso, Tyvaso |
| Paratek Pharmaceuticals, INC. | $198.38 | 2019-2025 | Nuzyra, Xhance |
| Viatris Specialty LLC | $169.38 | 2025 | Yupelri |
| Amgen INC. | $161.77 | 2022-2024 | Tezspire |
| Verona Pharma, INC. | $155.30 | 2025 | Ohtuvayre |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $136.18 | 2019 | |
| Insmed, INC. | $127.65 | 2022-2025 | Arikayce |
| Electromed, INC. | $126.16 | 2019-2023 | Smartvest |
| E.R. Squibb & Sons, L.L.C. | $124.10 | 2019-2021 | |
| Philips North America LLC | $120.00 | 2021-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Baxter Healthcare | $108.21 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Vifor Pharma, INC. | $82.86 | 2024-2025 | Zemaira, Veltassa |
| Sunovion Pharmaceuticals INC. | $77.44 | 2019-2020 | |
| Genentech USA, INC. | $74.22 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $66.99 | 2025 | |
| Advanced Respiratory, INC | $59.50 | 2019-2021 | |
| Shire North American Group INC | $56.10 | 2019 | |
| Ceribell, INC. | $37.77 | 2023 | Ceribell Rapid Response Eeg |
| Abbvie INC. | $29.55 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.76 | 2025 | |
| Ani Pharmaceuticals, INC. | $20.84 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.39 | 2021 | |
| Circassia INC. | $17.83 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.43 | 2021 | |
| Monaghan Medical Corporation | $15.75 | 2023 | Aeroeclipse |
| Janssen Pharmaceuticals, INC | $14.23 | 2021 | |
| Liquidia Technologies, INC. | $13.86 | 2025 | Yutrepia |
| Allergan, INC. | $13.12 | 2019 | |
| Inogen, INC. | $6.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nayneshkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.